On 19 May 2022 the National Blood Authority announced that five of Australia’s domestic plasma products will changing from early 2023. The products being replaced are:
INTRAGAM 10 (10% intravenous immunoglobulin)
EVOGAM (16% subcutaneous immunoglobulin)
ALBUMEX 4 (4% albumin)
ALBUMEX 20 (20% albumin)
PROTHROMBINEX-VF (prothrombin complex concentrate containing clotting factors II, IX and X)
More information on the changes and what hospitals and clinicians need to do to start preparing can be found here.